The last mile presents unique challenges for maintaining drug quality and integrity, both in terms of inaccurate planning and a lack of integration between internal systems. In this article, with insights from Henry Moran Chief Operating Officer, ASC Associates Ltd, we explore:
- Who is responsible for the last mile?
- How can you mitigate the two most common causes of disruption in the last mile?
- How will Internet of Things (IoT) shake things up in the last mile?
Approximately one-third of the medicines manufactured in Europe and the United States are now being tested and labeled for storage at controlled room temperature (CRT), mostly in the range of 15°C to 25°C and the proportion is increasing.
Pharma IQ sat down with Steve Winyard, Portfolio Strategy Manager Life Sciences at Inmark to discuss best practices for CRT transportation, an area which is facing increasing global regulatory scrutiny.
Cold chain partnerships are largely a matter of trust. Once cargo is handed to a forwarder or carrier, shippers must rely on their partners to safely steward their temperature-sensitive products through the cold chain. Effective, reliable partners should show low levels of wasted product from supply chain errors, because a tested and refined process best controls temperature fluctuations. We enlisted insight from; Guy Hoskens, Clinical Supply Chain Logistics Expert, Janssen, Alan Kennedy, Founder, Team-up Global and Luiz Barberini, Operations Manager- External Manufacturing Latin America Head, Bayer to examine some key collaboration mistakes that could trigger a break in a cold chain.
Multiple factors affect the decision to choose a particular mode of transport for pharmaceuticals. On the back of feedback received on the topic of air freight vs sea freight, Pharma IQ interviewed two industry experts about their thoughts on the continuing importance of air freight in the transportation of temperature controlled pharmaceuticals.